31 results on '"Perut, Francesca"'
Search Results
2. Association between Bone Turnover Markers and Fracture Healing in Long Bone Non-Union: A Systematic Review.
- Author
-
Perut, Francesca, Roncuzzi, Laura, Gómez-Barrena, Enrique, and Baldini, Nicola
- Subjects
- *
FRACTURE healing , *BONE remodeling , *BONE fractures , *HEALING , *CINAHL database , *GENETIC disorders - Abstract
Background: Fracture healing is a very complex and well-orchestrated regenerative process involving many cell types and molecular pathways. Despite the high efficiency of this process, unsatisfying healing outcomes, such as non-union, occur for approximately 5–10% of long bone fractures. Although there is an obvious need to identify markers to monitor the healing process and to predict a potential failure in callus formation to heal the fracture, circulating bone turnover markers' (BTMs) utility as biomarkers in association with radiographic and clinical examination still lacks evidence so far. Methods: A systematic review on the association between BTMs changes and fracture healing in long bone non-union was performed following PRISMA guidelines. The research papers were identified via the PubMed, Cochrane, Cinahl, Web of Science, Scopus, and Embase databases. Studies in which the failure of fracture healing was associated with osteoporosis or genetic disorders were not included. Results: A total of 172 studies were collected and, given the inclusion criteria, 14 manuscripts were included in this review. Changes in circulating BTMs levels were detected during the healing process and across groups (healed vs. non-union patients and healthy vs. patients with non-union). However, we found high heterogeneity in patients' characteristics (fracture site, gender, and age) and in sample scheduling, which made it impossible to perform a meta-analysis. Conclusions: Clinical findings and radiographic features remain the two important components of non-union diagnosis so far. We suggest improving blood sample standardization and clinical data collection in future research to lay the foundations for the effective use of BTMs as tools for diagnosing non-union. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Cell culture‐derived extracellular vesicles: Considerations for reporting cell culturing parameters.
- Author
-
Shekari, Faezeh, Alibhai, Faisal J., Baharvand, Hossein, Börger, Verena, Bruno, Stefania, Davies, Owen, Giebel, Bernd, Gimona, Mario, Salekdeh, Ghasem Hosseini, Martin‐Jaular, Lorena, Mathivanan, Suresh, Nelissen, Inge, Nolte‐'t Hoen, Esther, O'Driscoll, Lorraine, Perut, Francesca, Pluchino, Stefano, Pocsfalvi, Gabriella, Salomon, Carlos, Soekmadji, Carolina, and Staubach, Simon
- Subjects
EXTRACELLULAR vesicles ,CELL culture ,TASK forces ,REPRODUCIBLE research - Abstract
Cell culture‐conditioned medium (CCM) is a valuable source of extracellular vesicles (EVs) for basic scientific, therapeutic and diagnostic applications. Cell culturing parameters affect the biochemical composition, release and possibly the function of CCM‐derived EVs (CCM‐EV). The CCM‐EV task force of the Rigor and Standardization Subcommittee of the International Society for Extracellular Vesicles aims to identify relevant cell culturing parameters, describe their effects based on current knowledge, recommend reporting parameters and identify outstanding questions. While some recommendations are valid for all cell types, cell‐specific recommendations may need to be established for non‐mammalian sources, such as bacteria, yeast and plant cells. Current progress towards these goals is summarized in this perspective paper, along with a checklist to facilitate transparent reporting of cell culturing parameters to improve the reproducibility of CCM‐EV research. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Preparation method and growth factor content of platelet concentrate influence the osteogenic differentiation of bone marrow stromal cells
- Author
-
Perut, Francesca, Filardo, Giuseppe, Mariani, Erminia, Cenacchi, Annarita, Pratelli, Loredana, Devescovi, Valentina, Kon, Elizaveta, Marcacci, Maurilio, Facchini, Andrea, Baldini, Nicola, and Granchi, Donatella
- Published
- 2013
- Full Text
- View/download PDF
5. Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to Doxorubicin.
- Author
-
Cortini, Margherita, Macchi, Francesca, Reggiani, Francesca, Vitale, Emanuele, Lipreri, Maria Veronica, Perut, Francesca, Ciarrocchi, Alessia, Baldini, Nicola, and Avnet, Sofia
- Subjects
DISEASE progression ,IN vitro studies ,FIBRONECTINS ,OSTEOSARCOMA ,DOXORUBICIN ,RESEARCH funding ,EXTRACELLULAR space - Abstract
Simple Summary: The pathogenesis of osteosarcoma relies on complex interactions between developing cancer and surrounding tissue, which includes proteins of the extracellular matrix. Mapping ECM–cell interactions and ECM composition is highly important to understand and predict cancer response to chemotherapy and potentially give rise to alternative targets for therapy. Our study aims at generating a 3D model that recapitulates interactions of cancer cells with ECM components and with non-tumor stromal cells and at elucidating the role of ECM deposition in chemotherapy response. Dissecting the contribution of the tumor environment and the role of collagenic and non-collagenic proteins of the ECM will provide additional knowledge for the development of new antitumor strategies. The extracellular matrix (ECM) modulates cell behavior, shape, and viability as well as mechanical properties. In recent years, ECM disregulation and aberrant remodeling has gained considerable attention in cancer targeting and prevention since it may stimulate tumorigenesis and metastasis. Here, we developed an in vitro model that aims at mimicking the in vivo tumor microenvironment by recapitulating the interactions between osteosarcoma (OS) cells and ECM with respect to cancer progression. We long-term cultured 3D OS spheroids made of metastatic or non-metastatic OS cells mixed with mesenchymal stromal cells (MSCs); confirmed the deposition of ECM proteins such as Type I collagen, Type III collagen, and fibronectin by the stromal component at the interface between tumor cells and MSCs; and found that ECM secretion is inhibited by a neutralizing anti-IL-6 antibody, suggesting a new role of this cytokine in OS ECM deposition. Most importantly, we showed that the cytotoxic effect of doxorubicin is reduced by the presence of Type I collagen. We thus conclude that ECM protein deposition is crucial for modelling and studying drug response. Our results also suggest that targeting ECM proteins might improve the outcome of a subset of chemoresistant tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Flexible polymeric ultrathin film for mesenchymal stem cell differentiation
- Author
-
Pensabene, Virginia, Taccola, Silvia, Ricotti, Leonardo, Ciofani, Gianni, Menciassi, Arianna, Perut, Francesca, Salerno, Manuela, Dario, Paolo, and Baldini, Nicola
- Published
- 2011
- Full Text
- View/download PDF
7. Apatite formation on bioactive calcium-silicate cements for dentistry affects surface topography and human marrow stromal cells proliferation
- Author
-
Gandolfi, Maria Giovanna, Ciapetti, Gabriela, Taddei, Paola, Perut, Francesca, Tinti, Anna, Cardoso, Marcio Vivan, Van Meerbeek, Bart, and Prati, Carlo
- Published
- 2010
- Full Text
- View/download PDF
8. New Portland Cement–based Materials for Endodontics Mixed with Articaine Solution: A Study of Cellular Response
- Author
-
Gandolfi, Maria Giovanna, Perut, Francesca, Ciapetti, Gabriela, Mongiorgi, Romano, and Prati, Carlo
- Published
- 2008
- Full Text
- View/download PDF
9. In vitro evaluation of freeze-dried bone allografts combined with platelet rich plasma and human bone marrow stromal cells for tissue engineering
- Author
-
Cenni, Elisabetta, Perut, Francesca, Ciapetti, Gabriela, Savarino, Lucia, Dallari, Dante, Cenacchi, Annarita, Stagni, Cesare, Giunti, Armando, Fornasari, Pier Maria, and Baldini, Nicola
- Published
- 2009
- Full Text
- View/download PDF
10. Isolation, characterisation and osteogenic potential of human bone marrow stromal cells derived from the medullary cavity of the femur
- Author
-
Leonardi, Elisa, Devescovi, Valentina, Perut, Francesca, Ciapetti, Gabriela, and Giunti, Armando
- Published
- 2008
- Full Text
- View/download PDF
11. Ultrasound-guided injection of platelet-rich plasma or cord blood platelet-rich plasma in nonunion: a randomized controlled trial.
- Author
-
Rani, Nicola, Perut, Francesca, Granchi, Donatella, Sante, Giuseppe Di, Pennello, Enrico, Mazzotta, Alessandro, Dallari, Dante, and Baldini, Nicola
- Abstract
Aim: To compare the ability of autologous platelet-rich plasma (PRP) and cord blood PRP (PRPc) to accelerate bone healing. Patients & methods: 71 patients with mechanically stable nonunion were treated weekly (3 consecutive weeks) with ultrasound-guided percutaneous injections of PRP or PRPc in a controlled randomized clinical trial. The primary outcome was healing (12 months) and secondary outcomes were radiological evolution (2 and 6 months) and changes in pain intensity (6 months). Results & conclusion: Bone consolidation was assessed over time without significant differences between PRP and PRPc treatment. In patients with persistent nonunion, pain perception decreased more after PRP treatment. PRPc appears to be a valid alternative when specific clinical conditions suggest avoiding the use of autologous blood products. Although the regenerative capacity of bone tissue is well recognized, the fracture repair process may be impaired by unfavorable conditions resulting in delayed union or complete nonunion. In this scenario, the use of autologous blood derivates to accelerate bone healing has been proposed. The aim of this study was to compare the therapeutic efficacy of autologous platelet-rich plasma (PRP) and cord blood PRP (PRPc) in bone nonunion. PRPc contains high levels of cytokines and growth factors, has low immunogenicity and can be successfully stored until use. This study verified that bone consolidation was similar in PRP and PRPc treatments, thus supporting PRPc as a valid therapeutic option when clinical conditions discourage the use of autologous blood derivates. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Recent highlights on bone stem cells: a report from Bone Stem Cells 2009, and not only…
- Author
-
Cenni, Elisabetta, Perut, Francesca, Baglío, Serena Rubina, Fiorentini, Elisa, and Baldini, Nicola
- Published
- 2010
- Full Text
- View/download PDF
13. Endothelial Cells Incubated with Platelet-Rich Plasma Express PDGF-B and ICAM-1 and Induce Bone Marrow Stromal Cell Migration
- Author
-
Cenni, Elisabetta, Ciapetti, Gabriela, Granchi, Donatella, Fotia, Caterina, Perut, Francesca, Giunti, Armando, and Baldini, Nicola
- Published
- 2009
- Full Text
- View/download PDF
14. Biomimetic calcium-silicate cements aged in simulated body solutions. Osteoblast response and analyses of apatite coating
- Author
-
Gandolfi, Maria Giovanna, Ciapetti, Gabriela, Perut, Francesca, Taddei, Paola, Modena, Enrico, Rossi, Piermaria L., and Prati, Carlo
- Published
- 2009
15. The Emerging Roles of Extracellular Vesicles in Osteosarcoma.
- Author
-
Perut, Francesca, Roncuzzi, Laura, and Baldini, Nicola
- Subjects
OSTEOSARCOMA ,CELL communication ,CHEMICAL stability ,NUCLEIC acids ,RHEUMATOID arthritis - Abstract
Extracellular vesicles (EVs) are heterogeneous nanosized vesicles that are constitutively released by virtually all types of cells. They have been isolated in almost all body fluids. EVs cargo consists of various molecules (nucleic acids, proteins, lipids, and metabolites), that can be found on EVs surface and/or in their lumen. EVs structure confer stability and allow the transfer of their cargo to specific cell types over a distance. EVs play a critical role in intercellular communication in physiological and pathological settings. The broadening of knowledge on EVs improved our comprehension of cancer biology as far as tumor development, growth, metastasis, chemoresistance, and treatment are concerned. Increasing evidences suggest that EVs have a significant role in osteosarcoma (OS) development, progression, and metastatic process. The modulation of inflammatory communication pathways by EVs plays a critical role in OS and in other bone-related pathological conditions such as osteoarthritis and rheumatoid arthritis. In this review we describe the emerging data on the role of extracellular vesicles in osteosarcoma and discuss the effects and function of OS-derived EVs focusing on their future applicability in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
16. α,γ-Diketocarboxylic Acids and Their Esters Act as Carbonic Anhydrase IX and XII Selective Inhibitors.
- Author
-
Nocentini, Alessio, Lucidi, Alessia, Perut, Francesca, Massa, Annamaria, Tomaselli, Daniela, Gratteri, Paola, Baldini, Nicola, Rotili, Dante, Mai, Antonello, and Supuran, Claudiu T.
- Published
- 2019
- Full Text
- View/download PDF
17. Spheroid‐based 3D cell cultures identify salinomycin as a promising drug for the treatment of chondrosarcoma.
- Author
-
Perut, Francesca, Avnet, Sofia, Sbrana, Francesca V., Baldini, Nicola, and De Milito, Angelo
- Subjects
- *
CHONDROSARCOMA , *SALINOMYCIN , *AUTOPHAGY , *DOXORUBICIN , *CISPLATIN - Abstract
ABSTRACT: Chondrosarcoma (CS) is a cartilage malignancy of adulthood that is treated by surgery alone, since chemotherapy is considered ineffective. Unfortunately, a large proportion of patients with CS develop lung metastases, and several die of the disease. In this study, we compared 3D‐spheroid cultures and conventional cell monolayer models in order to identify the best way to select anticancer agents that could be effective for the systemic control of CS. Using SW1353 cells, we developed a three‐dimensional (3D) in vitro culture model to mimic in vivo features of CS microenvironment and evaluated the efficacy of different drugs to modulate CS cell proliferation and survival in 2D versus 3D‐cultures. Doxorubicin (DXR) and cisplatin, that are widely employed in sarcomas, were less effective on 3D‐CS spheroids when compared to standard monolayer models, whereas treatment with the ionophore salinomycin (SAL) had a strong cytotoxic effect both on 2D and 3D‐cultures. Furthermore, as demonstrated by the reduced viability and the enhanced DXR nuclear localization, SAL enhanced DXR cytotoxicity in 3D‐CS spheroids also at sub‐lethal doses. SAL activity on 3D‐CS spheroids was mediated by a significant induction of apoptosis via caspase activation. This study demonstrates that preclinical tests significantly differ in monolayer and 3D cultures of CS cells. Using this approach, SAL, alone or, at sub‐lethal concentrations, in combination with DXR, represents a promising agent for the systemic treatment of CS. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:2305–2312, 2018. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
18. The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells.
- Author
-
Sbrana, Francesca, Cortini, Margherita, Avnet, Sofia, Perut, Francesca, Columbaro, Marta, Milito, Angelo, and Baldini, Nicola
- Subjects
MESENCHYMAL stem cell differentiation ,AUTOPHAGY ,REGENERATIVE medicine ,PROGENITOR cells ,EUKARYOTIC cells ,HOMEOSTASIS - Abstract
Regulated self-consumption, also known as autophagy, is an evolutionary conserved process that degrades cellular components by directing them to the lysosomal compartment of eukaryotic cells. As a major intracellular degradation and recycling pathway, autophagy is crucial for maintaining and remodeling cellular homeostasis during normal cellular and tissue development. Recent studies have demonstrated that autophagy is necessary for the maintenance of cellular stemness and for a number of differentiation processes, including the lineage determination of mesenchymal stem cells. These are multipotent progenitor cells with self-renewal capacities that can give rise to a subset of tissues and thus hold a consistent potential in regenerative medicine. Here, we review the current literature on the complex liaison between autophagy induced by various extra- or intracellular stimuli and the molecular targets that affect mesenchymal stem cells proliferation and differentiation. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
19. Multimodal transfer of MDR by exosomes in human osteosarcoma.
- Author
-
TORREGGIANI, ELENA, RONCUZZI, LAURA, PERUT, FRANCESCA, ZINI, NICOLETTA, and BALDINI, NICOLA
- Published
- 2016
- Full Text
- View/download PDF
20. Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species.
- Author
-
Baglio, Serena Rubina, Rooijers, Koos, Koppers-Lalic, Danijela, Verweij, Frederik J., Lanzón, M. Pérez, Zini, Nicoletta, Naaijkens, Benno, Perut, Francesca, Niessen, Hans W. M., Baldini, Nicola, and Pegtel, D. Michiel
- Subjects
BONE marrow ,MESENCHYMAL stem cells ,ADIPOSE tissues ,EXOSOMES ,MICRORNA ,TRANSFER RNA ,CELLULAR therapy - Abstract
Introduction: Administration of mesenchymal stem cells (MSCs) represents a promising treatment option for patients suffering from immunological and degenerative disorders. Accumulating evidence indicates that the healing effects of MSCs are mainly related to unique paracrine properties, opening opportunities for secretome-based therapies. Apart from soluble factors, MSCs release functional small RNAs via extracellular vesicles (EVs) that seem to convey essential features of MSCs. Here we set out to characterize the full small RNAome of MSC-produced exosomes. Methods: We set up a protocol for isolating exosomes released by early passage adipose- (ASC) and bone marrow-MSCs (BMSC) and characterized them via electron microscopy, protein analysis and small RNA-sequencing. We developed a bioinformatics pipeline to define the exosome-enclosed RNA species and performed the first complete small RNA characterization of BMSCs and ASCs and their corresponding exosomes in biological replicates. Results: Our analysis revealed that primary ASCs and BMSCs have highly similar small RNA expression profiles dominated by miRNAs and snoRNAs (together 64-71 %), of which 150-200 miRNAs are present at physiological levels. In contrast, the miRNA pool in MSC exosomes is only 2-5 % of the total small RNAome and is dominated by a minor subset of miRNAs. Nevertheless, the miRNAs in exosomes do not merely reflect the cellular content and a defined set of miRNAs are overrepresented in exosomes compared to the cell of origin. Moreover, multiple highly expressed miRNAs are precluded from exosomal sorting, consistent with the notion that these miRNAs are involved in functional repression of RNA targets. While ASC and BMSC exosomes are similar in RNA class distribution and composition, we observed striking differences in the sorting of evolutionary conserved tRNA species that seems associated with the differentiation status of MSCs, as defined by Sox2, POU5F1A/B and Nanog expression. Conclusions: We demonstrate that primary MSCs release small RNAs via exosomes, which are increasingly implicated in intercellular communications. tRNAs species, and in particular tRNA halves, are preferentially released and their specific sorting into exosomes is related to MSC tissue origin and stemness. These findings may help to understand how MSCs impact neighboring or distant cells with possible consequences for their therapeutic usage. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. FT-IR Spectral Signature of Sensitive and Multidrug-Resistant Osteosarcoma Cell-Derived Extracellular Nanovesicles.
- Author
-
Perut, Francesca, Graziani, Gabriela, Roncuzzi, Laura, Zini, Nicoletta, Avnet, Sofia, and Baldini, Nicola
- Subjects
- *
MULTIDRUG-resistant tuberculosis , *DRUG resistance , *FOURIER transform infrared spectroscopy , *MESENCHYMAL stem cells , *OSTEOSARCOMA , *MULTIDRUG resistance - Abstract
Osteosarcoma (OS) is the most common primary bone cancer in children and adolescents. Despite aggressive treatment regimens, the outcome is unsatisfactory, and multidrug resistance (MDR) is a pivotal process in OS treatment failure. OS-derived extracellular vesicles (EVs) promote drug resistance to chemotherapy and target therapy through different mechanisms. The aim of this study was to identify subpopulations of osteosarcoma-EVs by Fourier transform infrared spectroscopy (FT-IR) to define a specific spectral signature for sensitive and multidrug-resistant OS-derived EVs. EVs were isolated from sensitive and MDR OS cells as well as from mesenchymal stem cells by differential centrifugation and ultracentrifugation. EVs size, morphology and protein expression were characterized. FT-IR/ATR of EVs spectra were acquired in the region of 400–4000 cm−1 (resolution 4 cm−1, 128 scans). The FT-IR spectra obtained were consistently different in the EVs compared to cells from which they originate. A specific spectral signature, characterized by a shift and a new band (1601 cm−1), permitted to clearly distinguish EVs isolated by sensitive and multidrug-resistant OS cells. Our data suggest that FT-IR spectroscopy allows to characterize and define a specific spectral signature for sensitive and MDR OS-derived EVs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
22. V-ATPase as an effective therapeutic target for sarcomas.
- Author
-
Perut, Francesca, Avnet, Sofia, Fotia, Caterina, Baglìo, Serena Rubina, Salerno, Manuela, Hosogi, Shigekuni, Kusuzaki, Katsuyuki, and Baldini, Nicola
- Subjects
- *
ADENOSINE triphosphatase , *CANCER treatment , *SARCOMA , *TARGETED drug delivery , *GLYCOLYSIS , *LACTATES , *OSTEOSARCOMA , *RHABDOMYOSARCOMA , *CHONDROSARCOMA , *LYSOSOMES , *PROTON pumps (Biology) - Abstract
Abstract: Malignant tumors show intense glycolysis and, as a consequence, high lactate production and proton efflux activity. We investigated proton dynamics in osteosarcoma, rhabdomyosarcoma, and chondrosarcoma, and evaluated the effects of esomeprazole as a therapeutic agent interfering with tumor acidic microenvironment. All sarcomas were able to survive in an acidic microenvironment (up to 5.9–6.0 pH) and abundant acidic lysosomes were found in all sarcoma subtypes. V-ATPase, a proton pump that acidifies intracellular compartments and transports protons across the plasma membrane, was detected in all cell types with a histotype-specific expression pattern. Esomeprazole administration interfered with proton compartmentalization in acidic organelles and induced a significant dose-dependent toxicity. Among the different histotypes, rhabdomyosarcoma, expressing the highest levels of V-ATPase and whose lysosomes are most acidic, was mostly susceptible to ESOM treatment. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
23. Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed.
- Author
-
Ferrari, Stefano, Perut, Francesca, Fagioli, Franca, Prever, Adalberto Brach Del, Meazza, Cristina, Parafioriti, Antonina, Picci, Piero, Gambarotti, Marco, Avnet, Sofia, Baldini, Nicola, and Fais, Stefano
- Subjects
- *
OSTEOSARCOMA , *PROTON pump inhibitors , *CANCER chemotherapy , *CELL proliferation , *CISPLATIN , *TUMOR growth , *XENOGRAFTS - Abstract
Background Major goals in translational oncology are to reduce systemic toxicity of current anticancer strategies and improve effectiveness. An extremely efficient cancer cell mechanism to avoid and/or reduce the effects of highly cytotoxic drugs is the establishment of an acidic microenvironment, an hallmark of all malignant tumors. The H + -rich milieu that anticancer drugs meet once they get inside the tumor leads to their protonation and neutralization, therefore hindering their access into tumor cells. We have previously shown that proton pump inhibitors (PPI) may efficiently counterattack this tumor advantage leading to a consistent chemosensitization of tumors. In this study, we investigated the effects of PPI in chemosensitizing osteosarcoma. Method MG-63 and Saos-2 cell lines were used as human osteosarcoma models. Cell proliferation after pretreatment with PPI and subsequent treatment with cisplatin was evaluated by using erythrosin B dye vital staining. Tumour growth was evaluated in xenograft treated with cisplatin after PPI pretreatment. Subsequently, a multi-centre historically controlled trial, was performed to evaluate the activity of a pre-treatment administration of PPIs as chemosensitizers during neoadjuvant chemotherapy based on methotrexate, cisplatin, and adriamycin. Results Preclinical experiments showed that PPI sensitize both human osteosarcoma cell lines and xenografts to cisplatin. A clinical study subsequently showed that pretreatment with PPI drug esomeprazole leads to an increase in the local effect of chemotherapy, as expressed by percentage of tumor necrosis. This was particularly evident in chondroblastic osteosarcoma, an histological subtype that normally shows a poor histological response. Notably, no significant increase in toxicity was recorded in PPI treated patients. Conclusion This study provides the first evidence that PPI may be beneficially added to standard regimens in combination to conventional chemotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
24. In vitro models for the evaluation of angiogenic potential in bone engineering.
- Author
-
Cenni, Elisabetta, Perut, Francesca, and Baldini, Nicola
- Subjects
HOMEOSTASIS ,BONE surgery ,TISSUE engineering ,NEOVASCULARIZATION ,CELL adhesion ,CELL proliferation ,RECOMBINANT proteins ,VASCULAR endothelial growth factors - Abstract
Blood vessels have a fundamental role both in skeletal homeostasis and in bone repair. Angiogenesis is also important for a successful bone engineering. Therefore, scaffolds should be tested for their ability to favour endothelial cell adhesion, proliferation and functions. The type of endothelial cell to use for in vitro assays should be carefully considered, because the properties of these cells may depend on their source. Morphological and functional relationships between endothelial cells and osteoblasts are evaluated with co-cultures, but this model should still be standardized, particularly for distinguishing the two cell types. Platelet-rich plasma and recombinant growth factors may be useful for stimulating angiogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
25. Background and rationale of platelet gel in orthopaedic surgery.
- Author
-
Cenni, Elisabetta, Savarino, Lucia, Perut, Francesca, Fotia, Caterina, Avnet, Sofia, and Sabbioni, Giacomo
- Subjects
BIOTHERAPY ,BLOOD platelets ,BONE regeneration ,CELL culture ,COMPARATIVE studies ,PHARMACEUTICAL gels ,RESEARCH methodology ,MEDICAL cooperation ,ORTHOPEDIC surgery ,RESEARCH ,EVALUATION research - Abstract
Autologous platelet gel, which is usually prepared by adding thrombin and calcium to a platelet concentrate, is used to accelerate bone repair as a possible alternative to recombinant growth factors (GF), through the osteogenic GF released from alpha-granules. The advantages of platelet gel lie in its mimicking the GF effects of the physiological bone healing and regenerative processes, in addition to a relatively simple and low cost technique. Moreover, if autologous platelet gel is used, immunological reactions are avoided. In in vitro systems, platelet gel stimulated osteogenic differentiation of bone marrow stromal cells, while it inhibited complete osteoclast differentiation and activation. Moreover, platelet gel favoured endothelial cell proliferation and expression of pro-osteogenic functions. In experimental animals and in clinical application, the efficacy of platelet gel was increased by the combination with bone allografts, acting as scaffolds, and with bone marrow stromal cells. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
26. The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma.
- Author
-
Avnet, Sofia, Lemma, Silvia, Cortini, Margherita, Di Pompo, Gemma, Perut, Francesca, Lipreri, Maria Veronica, Roncuzzi, Laura, Columbaro, Marta, Errani, Costantino, Longhi, Alessandra, Zini, Nicoletta, Heymann, Dominique, Dominici, Massimo, Grisendi, Giulia, Golinelli, Giulia, Consolino, Lorena, Longo, Dario Livio, Nanni, Cristina, Righi, Alberto, and Baldini, Nicola
- Subjects
RISK of metastasis ,BIOLOGICAL models ,INTERLEUKINS ,XENOGRAFTS ,IN vivo studies ,OSTEOSARCOMA ,CANCER invasiveness ,ANIMAL experimentation ,RISK assessment ,STEM cells ,INFLAMMATORY mediators ,ACIDOSIS ,MICE ,GLYCOLYSIS ,DISEASE complications - Abstract
Simple Summary: We aimed to validate the correlation between tumour glycolysis/acidosis and inflammation in osteosarcoma-associated mesenchymal stromal cells and investigate the role of acidity-induced inflammation in the development of metastasis in this very aggressive cancer. We confirmed the presence of an acidic microenvironment in osteosarcoma xenografts, both subcutaneous and orthotopic, using state-of-the-art imaging technologies; corroborated the correlation between tumour glycolysis, acidosis, and inflammatory markers in human patients; and finally, explored the use of anti-IL6 antibody to target these pathogenic pathways, using advanced 3D microfluidic models. In the future, advanced imaging systems for the measurement of tumour glycolysis and/or pH may help identify osteosarcoma patients who would benefit from anti-IL6 therapies to complement conventional therapy. Osteosarcoma is the most frequent primary malignant bone tumour with an impressive tendency to metastasise. Highly proliferative tumour cells release a remarkable amount of protons into the extracellular space that activates the NF-kB inflammatory pathway in adjacent stromal cells. In this study, we further validated the correlation between tumour glycolysis/acidosis and its role in metastases. In patients, at diagnosis, we found high circulating levels of inflammatory mediators (IL6, IL8 and miR-136-5p-containing extracellular vesicles). IL6 serum levels significantly correlated with disease-free survival and
18 F-FDG PET/CT uptake, an indirect measurement of tumour glycolysis and, hence, of acidosis. In vivo subcutaneous and orthotopic models, co-injected with mesenchymal stromal (MSC) and osteosarcoma cells, formed an acidic tumour microenvironment (mean pH 6.86, as assessed by in vivo MRI-CEST pH imaging). In these xenografts, we enlightened the expression of both IL6 and the NF-kB complex subunit in stromal cells infiltrating the tumour acidic area. The co-injection with MSC also significantly increased lung metastases. Finally, by using 3D microfluidic models, we directly showed the promotion of osteosarcoma invasiveness by acidosis via IL6 and MSC. In conclusion, osteosarcoma-associated MSC react to intratumoural acidosis by triggering an inflammatory response that, in turn, promotes tumour invasiveness at the primary site toward metastasis development. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
27. Strawberry-Derived Exosome-Like Nanoparticles Prevent Oxidative Stress in Human Mesenchymal Stromal Cells.
- Author
-
Perut, Francesca, Roncuzzi, Laura, Avnet, Sofia, Massa, Annamaria, Zini, Nicoletta, Sabbadini, Silvia, Giampieri, Francesca, Mezzetti, Bruno, and Baldini, Nicola
- Subjects
- *
STROMAL cells , *STRAWBERRIES , *OXIDATIVE stress , *FOLIC acid , *VITAMIN C , *OXIDANT status , *FUNGICIDE resistance - Abstract
Plant-derived exosome-like nanovesicles (EPDENs) have recently been isolated and evaluated as potential bioactive nutraceutical biomolecules. It has been hypothesized that EPDENs may exert their activity on mammalian cells through their specific cargo. In this study, we isolated and purified EPDENs from the strawberry juice of Fragaria x ananassa (cv. Romina), a new cultivar characterized by a high content of anthocyanins, folic acid, flavonols, and vitamin C and an elevated antioxidant capacity. Fragaria-derived EPDENs were purified by a series of centrifugation and filtration steps. EPDENs showed size and morphology similar to mammalian extracellular nanovesicles. The internalization of Fragaria-derived EPDENs by human mesenchymal stromal cells (MSCs) did not negatively affect their viability, and the pretreatment of MSCs with Fragaria-derived EPDENs prevented oxidative stress in a dose-dependent manner. This is possibly due to the presence of vitamin C inside the nanovesicle membrane. The analysis of EPDEN cargo also revealed the presence of small RNAs and miRNAs. These findings suggest that Fragaria-derived EPDENs may be considered nanoshuttles contained in food, with potential health-promoting activity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
28. Citrate Supplementation Restores the Impaired Mineralisation Resulting from the Acidic Microenvironment: An In Vitro Study.
- Author
-
Perut, Francesca, Graziani, Gabriela, Columbaro, Marta, Caudarella, Renata, Baldini, Nicola, and Granchi, Donatella
- Abstract
Chronic metabolic acidosis leads to bone-remodelling disorders based on excessive mineral matrix resorption and inhibition of bone formation, but also affects the homeostasis of citrate, which is an essential player in maintaining the acid–base balance and in driving the mineralisation process. This study aimed to investigate the impact of acidosis on the osteogenic properties of bone-forming cells and the effects of citrate supplementation in restoring the osteogenic features impaired by the acidic milieu. For this purpose, human mesenchymal stromal cells were cultured in an osteogenic medium and the extracellular matrix mineralisation was analysed at the micro- and nano-level, both in neutral and acidic conditions and after treatment with calcium citrate and potassium citrate. The acidic milieu significantly decreased the citrate release and hindered the organisation of the extracellular matrix, but the citrate supplementation increased collagen production and, particularly calcium citrate, promoted the mineralisation process. Moreover, the positive effect of citrate supplementation was observed also in the physiological microenvironment. This in vitro study proves that the mineral matrix organisation is influenced by citrate availability in the microenvironment surrounding bone-forming cells, thus providing a biological basis for using citrate-based supplements in the management of bone-remodelling disorders related to chronic low-grade acidosis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
29. Extracellular Nanovesicles Secreted by Human Osteosarcoma Cells Promote Angiogenesis.
- Author
-
Perut, Francesca, Roncuzzi, Laura, Zini, Nicoletta, Massa, Annamaria, and Baldini, Nicola
- Subjects
- *
CELL lines , *ENDOTHELIUM , *HYDROGEN-ion concentration , *NEOVASCULARIZATION , *OSTEOSARCOMA , *POULTRY , *MICRORNA , *EXOSOMES , *IN vitro studies , *IN vivo studies - Abstract
Angiogenesis involves a number of different players among which extracellular nanovesicles (EVs) have recently been proposed as an efficient cargo of pro-angiogenic mediators. Angiogenesis plays a key role in osteosarcoma (OS) development and progression. Acidity is a hallmark of malignancy in a variety of cancers, including sarcomas, as a result of an increased energetic metabolism. The aim of this study was to investigate the role of EVs derived from osteosarcoma cells on angiogenesis and whether extracellular acidity, generated by tumor metabolism, could influence EVs activity. For this purpose, we purified and characterized EVs from OS cells maintained at either acidic or neutral pH. The ability of EVs to induce angiogenesis was assessed in vitro by endothelial cell tube formation and in vivo using chicken chorioallantoic membrane. Our findings demonstrated that EVs derived from osteosarcoma cells maintained either in acidic or neutral conditions induced angiogenesis. The results showed that miRNA and protein content of EVs cargo are correlated with pro-angiogenic activity and this activity is increased by the acidity of tumor microenvironment. This study provides evidence that EVs released by human osteosarcoma cells act as carriers of active angiogenic stimuli that are able to promote endothelial cell functions relevant to angiogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
30. Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclasts
- Author
-
Avnet, Sofia, Pallotta, Rosanna, Perut, Francesca, Baldini, Nicola, Pittis, Maria Gabriela, Saponari, Anita, Lucarelli, Enrico, Dozza, Barbara, Greggi, Tiziana, Maraldi, Nadir M., Capanni, Cristina, Mattioli, Elisabetta, Columbaro, Marta, and Lattanzi, Giovanna
- Subjects
- *
GENETIC disorders , *DYSPLASIA , *BONE resorption , *OSTEOCLASTS , *GENETIC mutation , *TRANSFORMING growth factors-beta , *CELL differentiation - Abstract
Abstract: Mandibuloacral dysplasia type A (MADA) is a rare disease caused by mutations in the LMNA gene encoding A type lamins. Patients affected by mandibuloacral dysplasia type A suffer from partial lipodystrophy, skin abnormalities and accelerated aging. Typical of mandibuloacral dysplasia type A is also bone resorption at defined districts including terminal phalanges, mandible and clavicles. Little is known about the biological mechanism underlying osteolysis in mandibuloacral dysplasia type A. In the reported study, we analyzed an osteoblast primary culture derived from the cervical vertebrae of a mandibuloacral dysplasia type A patient bearing the homozygous R527H LMNA mutation. Mandibuloacral dysplasia type A osteoblasts showed nuclear abnormalities typical of laminopathic cells, but they proliferated in culture and underwent differentiation upon stimulation with dexamethasone and beta-glycerophosphate. Differentiated osteoblasts showed proper production of bone mineral matrix until passage 8 in culture, suggesting a good differentiation activity. In order to evaluate whether mandibuloacral dysplasia type A osteoblast-derived factors affected osteoclast differentiation or activity, we used a conditioned medium from mandibuloacral dysplasia type A or control cultures to treat normal human peripheral blood monocytes and investigated whether they were induced to differentiate into osteoclasts. A higher osteoclast differentiation and matrix digestion rate was obtained in the presence of mandibuloacral dysplasia type A osteoblast medium with respect to normal osteoblast medium. Further, TGFbeta 2 and osteoprotegerin expression were enhanced in mandibuloacral dysplasia type A osteoblasts while the RANKL/osteoprotegerin ratio was diminished. Importantly, inhibition of TGFbeta 2 by a neutralizing antibody abolished the effect of mandibuloacral dysplasia type A conditioned medium on osteoclast differentiation. These data argue in favor of an altered bone turnover in mandibuloacral dysplasia type A, caused by upregulation of bone-derived stimulatory cytokines, which activate non-canonical differentiation stimuli. In this context, TGFbeta 2 appears as a major player in the osteolytic process that affects mandibuloacral dysplasia type A patients. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
31. V-ATPase is a candidate therapeutic target for Ewing sarcoma.
- Author
-
Avnet, Sofia, Di Pompo, Gemma, Lemma, Silvia, Salerno, Manuela, Perut, Francesca, Bonuccelli, Gloria, Granchi, Donatella, Zini, Nicoletta, and Baldini, Nicola
- Subjects
- *
ADENOSINE triphosphatase , *EWING'S sarcoma , *OXIDATIVE phosphorylation , *GLYCOLYSIS , *GENETIC transcription , *CELL death , *THERAPEUTICS - Abstract
Abstract: Suppression of oxidative phosphorylation combined with enhanced aerobic glycolysis and the resulting increased generation of protons are common features of several types of cancer. An efficient mechanism to escape cell death resulting from intracellular acidification is proton pump activation. In Ewing sarcoma (ES), although the tumor-associated chimeric gene EWS-FLI1 is known to induce the accumulation of hypoxia-induced transcription factor HIF-1α, derangements in metabolic pathways have been neglected so far as candidate pathogenetic mechanisms. In this paper, we observed that ES cells simultaneously activate mitochondrial respiration and high levels of glycolysis. Moreover, although the most effective detoxification mechanism of proton intracellular storage is lysosomal compartmentalization, ES cells show a poorly represented lysosomal compartment, but a high sensitivity to the anti-lysosomal agent bafilomycin A1, targeting the V-ATPase proton pump. We therefore investigated the role of V-ATPase in the acidification activity of ES cells. ES cells with the highest GAPDH and V-ATPase expression also showed the highest acidification rate. Moreover, the localization of V-ATPase was both on the vacuolar and the plasma membrane of all ES cell lines. The acidic extracellular pH that we reproduced in vitro promoted high invasion ability and clonogenic efficiency. Finally, targeting V-ATPase with siRNA and omeprazole treatments, we obtained a significant selective reduction of tumor cell number. In summary, glycolytic activity and activation of V-ATPase are crucial mechanisms of survival of ES cells and can be considered as promising selective targets for the treatment of this tumor. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.